Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Open Access
- 5 July 2021
- preprint content
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
We estimated the duration and determinants of antibody response after SARS-CoV-2 infection in the general population using representative data from 7,256 United Kingdom COVID-19 infection survey participants who had positive swab SARS-CoV-2 PCR tests from 26-April-2020 to 14-June-2021. A latent class model classified 24% of participants as ‘non-responders’ not developing anti-spike antibodies. These seronegative non-responders were older, had higher SARS-CoV-2 cycle threshold values during infection (i.e. lower viral burden), and less frequently reported any symptoms. Among those who seroconverted, using Bayesian linear mixed models, the estimated anti-spike IgG peak level was 7.3-fold higher than the level previously associated with 50% protection against reinfection, with higher peak levels in older participants and those of non-white ethnicity. The estimated anti-spike IgG half-life was 184 days, being longer in females and those of white ethnicity. We estimated antibody levels associated with protection against reinfection likely last 1.5-2 years on average, with levels associated with protection from severe infection present for several years. These estimates could inform planning for vaccination booster strategies.Keywords
This publication has 44 references indexed in Scilit:
- Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based studycclm, 2020
- Sex differences in immune responses that underlie COVID-19 disease outcomesNature, 2020
- Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic InterventionsImmunity, 2020
- Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 InfectionsThe Journal of Infectious Diseases, 2020
- Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-respondersPublished by Cold Spring Harbor Laboratory ,2020
- A comparison study of SARS‐CoV‐2 IgG antibody between male and female COVID‐19 patients: A possible reason underlying different outcome between sexJournal of Medical Virology, 2020
- Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19The Journal of Applied Laboratory Medicine, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyThe Lancet Infectious Diseases, 2020
- Joint latent class models for longitudinal and time-to-event data: A reviewStatistical Methods in Medical Research, 2012